About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Health Regulators Approve Drug To Counter Effect Of Blood Thinner Pradaxa

by Shirley Johanna on October 17, 2015 at 5:45 PM
Font : A-A+

Health Regulators Approve Drug To Counter Effect Of Blood Thinner Pradaxa

A drug to reverse the blood-thinning effects of the popular pill Pradaxa, has been approved by the Food and Drug Administration.

Praxbind (idarucizumab) was cleared for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's blood-thinning effects.

Advertisement

Pradaxa is prescribed to prevent stroke and blood clots in people with a common heart rhythm disorder called atrial fibrillation, and for the treatment and prevention of deep venous thrombosis and pulmonary embolism (which usually occurs when clots that form in veins break free and travel to the lungs).

"The anticoagulant effects of Pradaxa are important and lifesaving for some patients, but there are situations where reversal of the drug's effects is medically necessary," Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products at the FDA's Center for Drug Evaluation and Research, said in an FDA news release. "Today's approval offers the medical community an important tool for managing patients taking Pradaxa in emergency or life-threatening situations when bleeding can't be controlled," he added.
Advertisement

The original drug, from Boehringer Ingelheim, was approved in 2010 to reduce the stroke risk in patients with irregular heartbeats, or atrial fibrillation. But unlike other blood-thinning medications, there was previously no antidote to stop the drug's effect.

In 2014, Boehringer agreed to pay $650 million to settle roughly 4,000 claims alleging that the company did not warn the public about the risks of uncontrolled bleeding with Pradaxa.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Thalassemia Congenital Heart Disease Signature Drug Toxicity Anticoagulants Hemophilia Health Insurance - India Blood in Stools - Symptom Evaluation Bombay Blood Group Common Side Effects of Anticoagulants / Blood Thinners 

Most Popular on Medindia

Indian Medical Journals Daily Calorie Requirements The Essence of Yoga Calculate Ideal Weight for Infants Blood - Sugar Chart Sanatogen Iron Intake Calculator Turmeric Powder - Health Benefits, Uses & Side Effects A-Z Drug Brands in India Find a Doctor
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Health Regulators Approve Drug To Counter Effect Of Blood Thinner Pradaxa Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests